PLEK2 promotes lung adenocarcinoma progression via activating the PI3K/AKT signaling pathway through SPC25 Running title: PLEK2 promotes LUAD via SPC25/PI3K/AKT axis
Preprint in Research Square (September 2023)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
Preprint in Research Square (September 2023)
Article in Frontiers in Immunology (May 2023)
Article in World Journal of Clinical Oncology (January 2023)